The effectiveness of intravenous Lidocaine used to treat pain related to peripheral potassium chloride infusion in adult hospitalized patients: a systematic review protocol

Abstract

REVIEW QUESTION/OBJECTIVE The objective of this review is to identify the effectiveness of intravenous Lidocaine used to treat pain related to peripheral potassium chloride infusion in adult patients in a hospital setting. INCLUSION CRITERIA Types of participants This review will consider studies that include all adult patients treated in the hospital setting who are the recipients of peripheral potassium chloride infusion. Adult patients are defined as all participants aged older than 18 years of age. Types of intervention(s) This review will consider studies that evaluate: Intravenous Lidocaine in any dosage including: 1.1% Lidocaine in 3mls diluent 2.50mg as a single dose 3.10mg Lidocaine as a single dose 4.or any other forms Diluents of Lidocaine in any form including: 1.0.9% saline 2.0.45% saline 3.5% dextrose in water 4.5% dextrose in 0.9% saline 5.5% dextrose in 0.45% saline 6.or any other types of diluents Frequency of Lidocaine administration including: in a single dose with any point of infusion as a continuous infusion as in a single dose prior to infusion as a single dose given in the midst of infusion as a single dose given at the end of infusion or any other types of frequencies As described by the primary researchers is effective in alleviating pain for peripheral intravenous potassium chloride infusion. Types of outcomes This review will consider studies that include measurement of pain score by using any validated pain scale described by the primary researchers. Examples of validated pain TRUNCATED AT 250 WORDS